Atlas Trials

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Clinical trial NCT03283319 · COMPLETED

Trial details

NCT number
NCT03283319
Sponsor
Biomedical Advanced Research and Development Authority
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza, Human
Start date
2017-09-20
Primary completion
2017-12-15
Enrollment
366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.